John A Hamilton Selected Research

Febrile Neutropenia

1/2018

The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Hamilton Research Topics

Disease

39	Inflammation (Inflammations) 04/2024 - 08/2002
20	Arthritis (Polyarthritis) 10/2023 - 08/2002
20	Pain (Aches) 10/2023 - 11/2009
18	Rheumatoid Arthritis 10/2023 - 03/2002
9	Peritonitis 04/2024 - 11/2003
8	Neoplasms (Cancer) 01/2023 - 06/2009
7	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 08/2002
6	Pneumonia (Pneumonitis) 01/2020 - 04/2004
6	Infections 01/2018 - 04/2004
4	Disease Progression 01/2016 - 08/2002
3	Osteoarthritis 10/2023 - 09/2012
3	Necrosis 01/2020 - 08/2002
3	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2014 - 11/2002
3	Experimental Arthritis 08/2011 - 03/2002
2	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2014
2	Neutropenia 01/2018 - 01/2018
2	Periodontitis 09/2015 - 06/2015
2	Wounds and Injuries (Trauma) 05/2014 - 01/2010
2	Stroke (Strokes) 04/2014 - 12/2013
2	Substance-Related Disorders (Drug Abuse) 04/2012 - 07/2006
2	Hypoxia (Hypoxemia) 01/2012 - 06/2009
1	Colitis 01/2024
1	Obesity 10/2023
1	Psoriatic Arthritis 01/2022
1	Chronic Pain 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	COVID-19 01/2020
1	Febrile Neutropenia 01/2018
1	Osteophyte 01/2018
1	Chronic Periodontitis 01/2017

Drug/Important Bio-Agent (IBA)

41	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2023 - 08/2002
21	CytokinesIBA 01/2022 - 08/2002
10	Macrophage Colony-Stimulating FactorIBA 10/2018 - 06/2002
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2024 - 08/2014
6	ZymosanIBA 04/2024 - 01/2017
6	Monoclonal AntibodiesIBA 01/2022 - 08/2011
6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2015 - 03/2002
5	methylated bovine serum albumin (MBSA)IBA 01/2020 - 11/2003
5	Fibrinolysin FDA Link 06/2015 - 09/2002
5	Plasminogen Activators (Plasminogen Activator)IBA 06/2015 - 03/2002
4	LigandsIBA 10/2023 - 12/2009
4	AntigensIBA 12/2016 - 01/2010
4	LipopolysaccharidesIBA 01/2011 - 11/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004 - 08/2002
3	Interleukin-23 (Interleukin 23)IBA 04/2024 - 01/2020
3	ChemokinesIBA 01/2023 - 01/2016
3	CollagenIBA 04/2016 - 01/2011
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 01/2010
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 05/2003
3	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2012 - 03/2002
2	Interleukin-23 Subunit p19IBA 04/2024 - 01/2022
2	GlucocorticoidsIBA 10/2023 - 01/2019
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2023 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2007
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
2	Nerve Growth Factor (NGF)IBA 11/2020 - 01/2020
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2020 - 02/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020 - 02/2013
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 02/2018
2	Interleukin-1 (Interleukin 1)IBA 01/2019 - 08/2002
2	Collagenases (Collagenase)FDA Link 01/2018 - 09/2012
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018 - 01/2017
2	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017 - 08/2014
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2016 - 07/2008
2	Interleukin-6 (Interleukin 6)IBA 12/2016 - 03/2008
2	AutoantibodiesIBA 01/2016 - 05/2013
2	Neutralizing AntibodiesIBA 08/2014 - 04/2004
2	Rosiglitazone (Avandia)FDA Link 04/2014 - 12/2013
2	Matrix Metalloproteinases (MMPs)IBA 09/2012 - 04/2004
2	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 04/2012 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 01/2005
2	FibrinIBA 04/2006 - 03/2002
2	EndotoxinsIBA 04/2004 - 05/2003
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2024
1	Ion Channels (Ion Channel)IBA 01/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2023
1	Chemotactic FactorsIBA 01/2023
1	guselkumabIBA 01/2022
1	InterleukinsIBA 01/2022
1	Conditioned Culture MediaIBA 11/2020
1	AZ10606120IBA 01/2020
1	Substance PIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	EicosanoidsIBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	mavrilimumabIBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	CCR4 ReceptorsIBA 01/2018
1	Cell Surface ReceptorsIBA 01/2017
1	InflammasomesIBA 01/2017
1	Interleukin-3 (Interleukin 3)IBA 12/2016
1	IntegrinsIBA 01/2016
1	Fc Receptors (Fc Receptor)IBA 01/2016
1	Complement System Proteins (Complement)IBA 01/2016

Therapy/Procedure

10	Therapeutics 01/2020 - 04/2007
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018
1	Investigational Therapies (Experimental Therapy) 02/2018
1	Drug Tapering 01/2018